NCT04522791 · Phase 2 · RECRUITING
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
This trial is testing whether combining a breathing technique called resonance frequency breathing with a computerized speed-and-attention training program can slow cognitive decline in older adults with mild cognitive impairment. Researchers are measuring brain and nervous system flexibility alongside memory and thinking skills over 14 months. This is a Phase 2 trial, meaning it is evaluating whether the approach works, not a proven or approved therapy.
Eligibility criteria
Inclusion Criteria: 1. All participants will require a diagnosis of "mild cognitive impairment due to Alzheimer's disease"using the most recent NIA and Alzheimer's Association workshop criteria: 1. Presence of memory complaint, 2. Rey Auditory Verbal Learning Test delayed recall (for memory) \< 6, 3. Montreal Cognitive Assessment (for global cognition) ranged 18 and 25, 4. Activities of Daily Living Questionnaire ≤ 30, 2. Intact score for San Diego Brief Assessment of Capacity to Consent (UBACC). 3. If a participant is on Alzheimer's disease medication (i.e., memantine or cholinesterase inhibitors), antidepressants, anxiolytics, or vascular risk or diseases related medications (e.g., beta- blocker), the dose should be stable for 3 months prior to recruitment. 4. Age 60-89, 5. English-speaking, 6. Adequate visual and hearing acuity for using mobile-based apps and testing by self-report, and 7. Community-dwelling. Exclusion Criteria: 1. Current enrollment in another cognitive improvement study; 2. Uncontrollable symptoms of major depression; 3. Major cerebrovascular and cardiovascular diseases (e.g., congestive heart failure, pacemaker, prior myocardial infarction); 4. Neurological diseases (e.g., Parkinson's disease, Multiple Sclerosis); 5. Having an active legal guardian (indicating impaired capacity for decision making); 6. MRI contraindication (e.g., pacemaker, claustrophobia). 7. Color blindedness 8. Alcohol dependency in the past 5 years that are the main contributor to MCI
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-07-09